Cargando…
COVID-19 Severity and Survival over Time in Vaccinated Patients with Hematologic Malignancies
| Autores principales: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The American Society of Hematology. Published by Elsevier Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9665213/ http://dx.doi.org/10.1182/blood-2022-169545 |
| _version_ | 1784831240885501952 |
|---|---|
| author | Martinez Lopez, Joaquin De La Cruz, Javier Gil-Manso, Rodrigo Benavente Cuesta, Celina Benito, Lauren Hernandez, jose Angel Herraez, Maria Regina Herrera Puente, Pilar Kwon, Mi Quiroz, Keina Arroyo, Andres Alegre, Adrian Llamas Sillero, María Pilar López Jiménez, Javier Sanchez-Godoy, Pedro Duarte, Rafael F. Diez Martin, Jose L. Jiménez-Yuste, Víctor Garcia-Suarez, Julio |
| author_facet | Martinez Lopez, Joaquin De La Cruz, Javier Gil-Manso, Rodrigo Benavente Cuesta, Celina Benito, Lauren Hernandez, jose Angel Herraez, Maria Regina Herrera Puente, Pilar Kwon, Mi Quiroz, Keina Arroyo, Andres Alegre, Adrian Llamas Sillero, María Pilar López Jiménez, Javier Sanchez-Godoy, Pedro Duarte, Rafael F. Diez Martin, Jose L. Jiménez-Yuste, Víctor Garcia-Suarez, Julio |
| author_sort | Martinez Lopez, Joaquin |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9665213 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | The American Society of Hematology. Published by Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-96652132022-11-16 COVID-19 Severity and Survival over Time in Vaccinated Patients with Hematologic Malignancies Martinez Lopez, Joaquin De La Cruz, Javier Gil-Manso, Rodrigo Benavente Cuesta, Celina Benito, Lauren Hernandez, jose Angel Herraez, Maria Regina Herrera Puente, Pilar Kwon, Mi Quiroz, Keina Arroyo, Andres Alegre, Adrian Llamas Sillero, María Pilar López Jiménez, Javier Sanchez-Godoy, Pedro Duarte, Rafael F. Diez Martin, Jose L. Jiménez-Yuste, Víctor Garcia-Suarez, Julio Blood Poster Abstracts The American Society of Hematology. Published by Elsevier Inc. 2022-11-15 2022-11-15 /pmc/articles/PMC9665213/ http://dx.doi.org/10.1182/blood-2022-169545 Text en Copyright © 2022 The American Society of Hematology. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Poster Abstracts Martinez Lopez, Joaquin De La Cruz, Javier Gil-Manso, Rodrigo Benavente Cuesta, Celina Benito, Lauren Hernandez, jose Angel Herraez, Maria Regina Herrera Puente, Pilar Kwon, Mi Quiroz, Keina Arroyo, Andres Alegre, Adrian Llamas Sillero, María Pilar López Jiménez, Javier Sanchez-Godoy, Pedro Duarte, Rafael F. Diez Martin, Jose L. Jiménez-Yuste, Víctor Garcia-Suarez, Julio COVID-19 Severity and Survival over Time in Vaccinated Patients with Hematologic Malignancies |
| title | COVID-19 Severity and Survival over Time in Vaccinated Patients with Hematologic Malignancies |
| title_full | COVID-19 Severity and Survival over Time in Vaccinated Patients with Hematologic Malignancies |
| title_fullStr | COVID-19 Severity and Survival over Time in Vaccinated Patients with Hematologic Malignancies |
| title_full_unstemmed | COVID-19 Severity and Survival over Time in Vaccinated Patients with Hematologic Malignancies |
| title_short | COVID-19 Severity and Survival over Time in Vaccinated Patients with Hematologic Malignancies |
| title_sort | covid-19 severity and survival over time in vaccinated patients with hematologic malignancies |
| topic | Poster Abstracts |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9665213/ http://dx.doi.org/10.1182/blood-2022-169545 |
| work_keys_str_mv | AT martinezlopezjoaquin covid19severityandsurvivalovertimeinvaccinatedpatientswithhematologicmalignancies AT delacruzjavier covid19severityandsurvivalovertimeinvaccinatedpatientswithhematologicmalignancies AT gilmansorodrigo covid19severityandsurvivalovertimeinvaccinatedpatientswithhematologicmalignancies AT benaventecuestacelina covid19severityandsurvivalovertimeinvaccinatedpatientswithhematologicmalignancies AT benitolauren covid19severityandsurvivalovertimeinvaccinatedpatientswithhematologicmalignancies AT hernandezjoseangel covid19severityandsurvivalovertimeinvaccinatedpatientswithhematologicmalignancies AT herraezmariaregina covid19severityandsurvivalovertimeinvaccinatedpatientswithhematologicmalignancies AT herrerapuentepilar covid19severityandsurvivalovertimeinvaccinatedpatientswithhematologicmalignancies AT kwonmi covid19severityandsurvivalovertimeinvaccinatedpatientswithhematologicmalignancies AT quirozkeina covid19severityandsurvivalovertimeinvaccinatedpatientswithhematologicmalignancies AT arroyoandres covid19severityandsurvivalovertimeinvaccinatedpatientswithhematologicmalignancies AT alegreadrian covid19severityandsurvivalovertimeinvaccinatedpatientswithhematologicmalignancies AT llamassilleromariapilar covid19severityandsurvivalovertimeinvaccinatedpatientswithhematologicmalignancies AT lopezjimenezjavier covid19severityandsurvivalovertimeinvaccinatedpatientswithhematologicmalignancies AT sanchezgodoypedro covid19severityandsurvivalovertimeinvaccinatedpatientswithhematologicmalignancies AT duarterafaelf covid19severityandsurvivalovertimeinvaccinatedpatientswithhematologicmalignancies AT diezmartinjosel covid19severityandsurvivalovertimeinvaccinatedpatientswithhematologicmalignancies AT jimenezyustevictor covid19severityandsurvivalovertimeinvaccinatedpatientswithhematologicmalignancies AT garciasuarezjulio covid19severityandsurvivalovertimeinvaccinatedpatientswithhematologicmalignancies |